Pelizaeus-Merzbacher disease: genes and variants
Explore variant evidence for Pelizaeus-Merzbacher disease across 1 analyzed protein (PLP1). Linked ClinVar records include 51 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pelizaeus-Merzbacher disease
PLP1: Myelin proteolipid protein
It supports central-nervous-system myelin structure and is required for oligodendrocyte and axonal integrity. Gene duplication most commonly causes Pelizaeus-Merzbacher disease, while other variants can cause spastic paraplegia type 2 or milder leukodystrophy.
51 ClinVar pathogenic / likely pathogenic and 26 uncertain variants in PLP1 have source records linked to Pelizaeus-Merzbacher disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pelizaeus-Merzbacher disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PLP1 L31R | 31 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PLP1 C220G | 220 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| PLP1 M1R | 1 | Pathogenic / likely pathogenic (★★) | |
| PLP1 F32L | 32 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PLP1 W163R | 163 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PLP1 D203N | 203 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 P216L | 216 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 S226P | 226 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 L85R | 85 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PLP1 P15L | 15 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PLP1 I47T | 47 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 Y58C | 58 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PLP1 H148Y | 148 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PLP1 L31P | 31 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 Y207H | 207 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 Y207N | 207 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 C220R | 220 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 A243E | 243 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 A243V | 243 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 M1K | 1 | Pathogenic / likely pathogenic (★) | |
| PLP1 G28E | 28 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 C35R | 35 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L40H | 40 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 T41P | 41 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 G42D | 42 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 P173S | 173 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 C184Y | 184 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 M206R | 206 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 L210F | 210 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 V219G | 219 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 S222C | 222 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 F237V | 237 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 F244V | 244 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 G246W | 246 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 A248E | 248 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L251P | 251 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 S253F | 253 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L254P | 254 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L19P | 19 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L46P | 46 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 F51V | 51 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 Q69L | 69 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 G74E | 74 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 A76P | 76 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L81R | 81 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 L87P | 87 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 K151N | 151 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| PLP1 C169R | 169 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PLP1 E232K | 232 | Extracellular | Pathogenic / likely pathogenic (★) |
| PLP1 T116K | 116 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Hereditary spastic paraplegia also has ClinVar records linked to PLP1 variants; they fall partly in the same places as the Pelizaeus-Merzbacher disease variants (14 pathogenic / likely pathogenic).
Diseases related to Pelizaeus-Merzbacher disease
- Hereditary spastic paraplegia, also linked to PLP1
- Auditory neuropathy, also linked to PLP1
Frequently asked questions
Which genes have records linked to Pelizaeus-Merzbacher disease?
This view contains 1 analyzed proteins: PLP1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 51 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 105 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center